Poor myeloid engraftment remains a barrier to experimental use of humanized mice. Focusing primarily on peripheral blood cells, we compared the engraftment profile of NOD-scid-IL2Rγc−/− (NSG) mice with that of NSG mice transgenic for human membrane stem cell factor (hu-mSCF mice), NSG mice transgenic for human interleukin (IL)-3, granulocyte-macrophage-colony stimulating factor (GM-CSF), and stem cell factor (SGM3 mice). hu-mSCF and SGM3 mice showed enhanced engraftment of human leukocytes compared to NSG mice, and this was reflected in the number of human neutrophils and monocytes present in these strains. Importantly, discrete classical, intermediate, and nonclassical monocyte populations were identifiable in the blood of NSG and hu-mSCF mice, while the nonclassical population was absent in the blood of SGM3 mice. Granulocyte-colony stimulating factor (GCSF) treatment increased the number of blood monocytes in NSG and hu-mSCF mice, and neutrophils in NSG and SGM3 mice; however, this effect appeared to be at least partially dependent on the stem cell donor used to engraft the mice. Furthermore, GCSF treatment resulted in a preferential expansion of nonclassical monocytes in both NSG and hu-mSCF mice. Human tubulointerstitial CD11c+ cells were present in the kidneys of hu-mSCF mice, while monocytes and neutrophils were identified in the liver of all strains. Bone marrow-derived macrophages prepared from NSG mice were most effective at phagocytosing polystyrene beads. In conclusion, hu-mSCF mice provide the best environment for the generation of human myeloid cells, with GCSF treatment further enhancing peripheral blood human monocyte cell numbers in this strain.
Get full access to this article
View all access options for this article.
References
1.
ManzMG. (2007). Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity, 26:537–541.
2.
ShultzLD, IshikawaF and GreinerDL. (2007). Humanized mice in translational biomedical research. Nat Rev Immunol, 7:118–130.
3.
MeazzaR, AzzaroneB, OrengoAM and FerriniS. (2011). Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. J Biomed Biotechnol, 2011:861920.
4.
IshikawaF, YasukawaM, LyonsB, YoshidaS, MiyamotoT, YoshimotoG, WatanabeT, AkashiK, ShultzLD and HaradaM. (2005). Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood, 106:1565–1573.
5.
ItoM, KobayashiK and NakahataT. (2008). NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol, 324:53–76.
6.
TraggiaiE, ChichaL, MazzucchelliL, BronzL, PiffarettiJ-C, LanzavecchiaA and ManzMG. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science, 304:104–107.
7.
McDermottSP, EppertK, LechmanER, DoedensM and DickJE. (2010). Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood, 116:193–200.
8.
BrehmMA, CuthbertA, YangC, MillerDM, DiIorioP, LaningJ, BurzenskiL, GottB, ForemanO, et al. (2010). Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol, 135:84–98.
9.
StoddartCA, MaidjiE, GalkinaSA, KosikovaG, RiveraJM, MorenoME, SloanB, JoshiP and LongBR. (2011). Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice. Virology, 417:154–160.
10.
BalazsAB, ChenJ, HongCM, RaoDS, YangL and BaltimoreD. (2012). Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature, 481:81–84.
11.
MurookaTT, DeruazM, MarangoniF, VrbanacVD, SeungE, von AndrianUH, TagerAM, LusterAD and MempelTR. (2012). HIV-infected T cells are migratory vehicles for viral dissemination. Nature, 490:283–287.
12.
DoshiM, KoyanagiM, NakaharaM, SaekiK, SaekiK and YuoA. (2006). Identification of human neutrophils during experimentally induced inflammation in mice with transplanted CD34+ cells from human umbilical cord blood. Int J Hematol, 84:231–237.
13.
CoughlanAM, FreeleySJ and RobsonMG. (2012). Humanised mice have functional human neutrophils. J Immunol Methods, 385:96–104.
14.
TanakaS, SaitoY, KunisawaJ, KurashimaY, WakeT, SuzukiN, ShultzLD, KiyonoH and IshikawaF. (2012). Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J Immunol, 188:6145–6155.
15.
HaraT and MiyajimaA. (1992). Two distinct functional high affinity receptors for mouse interleukin-3 (IL-3). EMBO J, 11:1875–1884.
16.
ShanafeltAB, JohnsonKE and KasteleinRA. (1991). Identification of critical amino acid residues in human and mouse granulocyte-macrophage colony-stimulating factor and their involvement in species specificity. J Biol Chem, 266:13804–13810.
17.
RongvauxA, WillingerT, TakizawaH, RathinamC, EynonE, StevensS, ManzM and FlavellR. (2011). Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. J Immunol, 186:153.5.
18.
TakagiS, SaitoY and HijikataA. (2012). Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Hematop Stem Cells, 119:1–3.
19.
BrehmMA, RackiWJ, LeifJ, BurzenskiL, HosurV, WetmoreA, GottB, HerlihyM, IgnotzR, et al. (2012). Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2r??null mice is enhanced by transgenic expression of membrane-bound human SCF. Blood, 119:2778–2788.
20.
BillerbeckE, BarryWT, MuK, DornerM, RiceCM and PlossA. (2011). Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ null humanized mice. Blood, 117:3076–3086.
21.
ReddyEP, KorapatiA, ChaturvediP and RaneS. (2000). IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene, 19:2532–2547.
22.
SchroederJT, ChichesterKL and BienemanAP. (2009). Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J Immunol, 182:2432–2438.
23.
ShiY, LiuCH, RobertsAI, DasJ, XuG, RenG, ZhangY, ZhangL, YuanZR, et al. (2006). Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res, 16:126–133.
24.
EgelandT, SteenR, QuarstenH, GaudernackG, YangYC and ThorsbyE. (1991). Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3. Blood, 78:3192–3199.
25.
SaelandS, CauxC, FavreC, DuvertV, PébusqueMJ, MannoniP and deVriesJE. (1989). Combined and sequential effects of human IL-3 and GM-CSF on the proliferation of CD34+ hematopoietic cells from cord blood. Blood, 73:1195–1201.
26.
CollRC, RobertsonA, ButlerM, Cooper andM, O'NeillLAJ. (2011). The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes. PLoS One, 6:e29539.
27.
TrouplinV, BoucheritN, GorvelL, ContiF, MottolaG and GhigoE. (2013). Bone marrow-derived macrophage production. J Vis Exp, 81:e50966.
28.
GeissmannF, JungS and LittmanDR. (2003). Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity, 19:71–82.
29.
CrosJ, CagnardN, WoollardK, PateyN, ZhangSY, SenechalB, PuelA, BiswasSK, MoshousD, et al. (2010). Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity, 33:375–386.
30.
BelgeK-U, DayyaniF, HoreltA, SiedlarM, FrankenbergerM, FrankenbergerB, EspevikT and Ziegler-HeitbrockL. (2002). The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol, 168:3536–3542.
31.
Grage-GriebenowE, LorenzenD, FettingR, FladHD and ErnstM. (1993). Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol, 23:3126–3135.
32.
WongKL, TaiJJ-Y, WongW-C, HanH, SemX, YeapW-H, KourilskyP and WongS-C. (2011). Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood, 118:e16–e31.
33.
RongvauxA, WillingerT, MartinekJ, StrowigT, GeartySV, TeichmannLL, SaitoY, MarchesF, HaleneS, et al. (2014). Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol, 32:364–372.
34.
MoniuszkoM, Bodzenta-LukaszykA, KowalK, LenczewskaD and DabrowskaM. (2009). Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients. Clin Immunol, 130:338–346.
35.
WaschbischA, SchroederS, LeeD-H, PfeifenbringS, Stadelmann-NesslerC and LinkerR. (2013). Non-classical and intermediate monocytes in the peripheral blood and cerebrospinal fluid of multiple sclerosis patients (P03.228). Neurology, 80:P03.228.
36.
ElghetanyM. (2002). Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis, 28:260–274.
37.
SunamiK. (2001). Administration of granulocyte colony-stimulating factor induces hyporesponsiveness to lipopolysaccharide and impairs antigen-presenting function of peripheral blood monocytes. Exp Hematol, 29:1117–1124.
38.
TanakaM, HondaJ, ImamuraY, ShiraishiK, TanakaK and OizumiK. (1999). Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors. Clin Exp Immunol, 116:57–61.
39.
RatomskiK, PłonowskiM, Zelazowska-RutkowskaB, ZakJ, WysockaJ and Krawczuk-RybakM. (2011). [Subpopulation of CD14+CD16+ monocytes in the children with acute lymphoblastic leukemia treated with filgrastim]. Pol Merkur Lekarski, 30:111–115.
40.
PerdigueroEG, KlapprothK, SchulzC, BuschK, AzzoniE, CrozetL, GarnerH, TrouilletC, de BruijnMF, GeissmannF and RodewaldH-R. (2014). Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature, 518:547–551.
41.
RathinamC, PoueymirouWT, RojasJ, MurphyAJ, ValenzuelaDM, YancopoulosGD, RongvauxA, EynonEE, ManzMG and FlavellRA. (2011). Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood, 118:3119–3128.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
